These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37105210)
1. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study. de Masson A; Beylot-Barry M; Ram-Wolff C; Mear JB; Dalle S; d'Incan M; Ingen-Housz-Oro S; Orvain C; Abraham J; Dereure O; Charbonnier A; Cornillon J; Longvert C; Barete S; Boulinguez S; Wierzbicka-Hainaut E; Aubin F; Rubio MT; Bernard M; Schmidt-Tanguy A; Houot R; Pham-Ledard A; Michonneau D; Brice P; Labussière-Wallet H; Bouaziz JD; Grange F; Moins-Teisserenc H; Jondeau K; Michel L; Mourah S; Battistella M; Daguindau E; Loschi M; Picard A; Franck N; Maillard N; Huynh A; Nguyen S; Marçais A; Chaby G; Ceballos P; Le Corre Y; Maury S; Bay JO; Adamski H; Bachy E; Forcade E; Socié G; Bagot M; Chevret S; Peffault de Latour R; ; ; Lancet; 2023 Jun; 401(10392):1941-1950. PubMed ID: 37105210 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. Domingo-Domenech E; Duarte RF; Boumedil A; Onida F; Gabriel I; Finel H; Arcese W; Browne P; Beelen D; Kobbe G; Veelken H; Arranz R; Greinix H; Lenhoff S; Poiré X; Ribera JM; Thompson J; Zuckerman T; Mufti GJ; Cortelezzi A; Olavarria E; Dreger P; Sureda A; Montoto S Bone Marrow Transplant; 2021 Jun; 56(6):1391-1401. PubMed ID: 33420392 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma. Goyal A; Foss F Expert Rev Anticancer Ther; 2024; 24(1-2):41-58. PubMed ID: 38224371 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. de Masson A; Beylot-Barry M; Bouaziz JD; Peffault de Latour R; Aubin F; Garciaz S; d'Incan M; Dereure O; Dalle S; Dompmartin A; Suarez F; Battistella M; Vignon-Pennamen MD; Rivet J; Adamski H; Brice P; François S; Lissandre S; Turlure P; Wierzbicka-Hainaut E; Brissot E; Dulery R; Servais S; Ravinet A; Tabrizi R; Ingen-Housz-Oro S; Joly P; Socié G; Bagot M; Haematologica; 2014 Mar; 99(3):527-34. PubMed ID: 24213148 [TBL] [Abstract][Full Text] [Related]
5. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Kim YH; Bagot M; Pinter-Brown L; Rook AH; Porcu P; Horwitz SM; Whittaker S; Tokura Y; Vermeer M; Zinzani PL; Sokol L; Morris S; Kim EJ; Ortiz-Romero PL; Eradat H; Scarisbrick J; Tsianakas A; Elmets C; Dalle S; Fisher DC; Halwani A; Poligone B; Greer J; Fierro MT; Khot A; Moskowitz AJ; Musiek A; Shustov A; Pro B; Geskin LJ; Dwyer K; Moriya J; Leoni M; Humphrey JS; Hudgens S; Grebennik DO; Tobinai K; Duvic M; Lancet Oncol; 2018 Sep; 19(9):1192-1204. PubMed ID: 30100375 [TBL] [Abstract][Full Text] [Related]
6. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides. Molina A; Zain J; Arber DA; Angelopolou M; O'Donnell M; Murata-Collins J; Forman SJ; Nademanee A J Clin Oncol; 2005 Sep; 23(25):6163-71. PubMed ID: 16135483 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: a concise review. Johnson WT; Mukherji R; Kartan S; Nikbakht N; Porcu P; Alpdogan O Chin Clin Oncol; 2019 Feb; 8(1):12. PubMed ID: 30525754 [TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome. Shiratori S; Fujimoto K; Nishimura M; Hatanaka KC; Kosugi-Kanaya M; Okada K; Sugita J; Shigematsu A; Hashimoto D; Endo T; Kondo T; Abe R; Hashino S; Matsuno Y; Shimizu H; Teshima T Hematol Oncol; 2016 Mar; 34(1):9-16. PubMed ID: 25312300 [TBL] [Abstract][Full Text] [Related]
9. Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas. Isufi I; Seropian S; Gowda L; Wilson LD; Roberts K; Girardi M; Perreault S; Foss F Leuk Lymphoma; 2020 Dec; 61(12):2955-2961. PubMed ID: 32643494 [TBL] [Abstract][Full Text] [Related]
10. A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome. Jacobsen ED; Kim HT; Ho VT; Cutler CS; Koreth J; Fisher DC; Armand P; Alyea EP; Freedman AS; Soiffer RJ; Antin JH Ann Oncol; 2011 Jul; 22(7):1608-1613. PubMed ID: 21252059 [TBL] [Abstract][Full Text] [Related]
11. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial. Marks DI; Clifton-Hadley L; Copland M; Hussain J; Menne TF; McMillan A; Moorman AV; Morley N; Okasha D; Patel B; Patrick P; Potter MN; Rowntree CJ; Kirkwood AA; Fielding AK Lancet Haematol; 2022 Apr; 9(4):e276-e288. PubMed ID: 35358442 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas. Dumont M; Peffault de Latour R; Ram-Wolff C; Bagot M; de Masson A Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33023002 [TBL] [Abstract][Full Text] [Related]
13. Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome. Mori T; Shiratori S; Suzumiya J; Kurokawa M; Shindo M; Naoyuki U; Katsuto T; Miyamoto T; Morishige S; Hirokawa M; Fukuda T; Atsuta Y; Suzuki R Hematol Oncol; 2020 Aug; 38(3):266-271. PubMed ID: 32011008 [TBL] [Abstract][Full Text] [Related]
14. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843 [TBL] [Abstract][Full Text] [Related]
15. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. Peinemann F; Bartel C; Grouven U Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658 [TBL] [Abstract][Full Text] [Related]